Covid-19 roundup: US and Pfizer strike deal for 100M more doses; NIH and partners cut critically ill patients out of blood thinner trial

Nicole DeFeudis

Editor

The US government has sealed a deal with Pfizer and BioNTech for 100 million additional doses of their Covid-19 vaccine, doubling the country’s dose order …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: US and Pfizer strike deal for 100M more doses; NIH and partners cut critically ill patients out of blood thinner trial

Nicole DeFeudis

Editor

Sign up to read this article for free.

Merck’s long-awaited obesity move is an oral GLP-1 from China

Novo Nordisk partners with Broad Institute spinout Photys after the startup's layoffs

Flagship gene therapy startup Ring Therapeutics nearly halves workforce in latest job cuts

Exclusive: Insitro makes headway on the harder road, discovering new ALS drug target

SiteOne Therapeutics, a pain biotech that's partnered with Vertex, nabs $100M

Tessera gets up to $50M from the Gates Foundation; Tvardi’s reverse merger

Covid-19 roundup: US and Pfiz­er strike deal for 100M more dos­es; NIH and part­ners cut crit­i­cal­ly ill pa­tients out of blood thin­ner tri­al

Nicole DeFeudis

Editor

Sign up to read this article for free.

more like this

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force in lat­est job cuts

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

SiteOne Ther­a­peu­tics, a pain biotech that's part­nered with Ver­tex, nabs $100M

Tessera gets up to $50M from the Gates Foun­da­tion; Tvar­di’s re­verse merg­er

Covid-19 roundup: US and Pfizer strike deal for 100M more doses; NIH and partners cut critically ill patients out of blood thinner trial

Merck’s long-awaited obesity move is an oral GLP-1 from China

Novo Nordisk partners with Broad Institute spinout Photys after the startup's layoffs

Flagship gene therapy startup Ring Therapeutics nearly halves workforce in latest job cuts

Exclusive: Insitro makes headway on the harder road, discovering new ALS drug target

SiteOne Therapeutics, a pain biotech that's partnered with Vertex, nabs $100M

Tessera gets up to $50M from the Gates Foundation; Tvardi’s reverse merger